209 related items for PubMed ID: 6574529
21. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
[Abstract] [Full Text] [Related]
22. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
Kathol RG, Jaeckle RS, Lopez JF, Meller WH.
Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
[Abstract] [Full Text] [Related]
23. The dexamethasone suppression test in prepubertal depressed children.
Weller EB, Weller RA, Fristad MA, Preskorn SH, Teare M.
J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
[Abstract] [Full Text] [Related]
24. Monoamine oxidase and cortisol response in depression and schizophrenia.
Pandey GN, Sharma RP, Janicak PG, Davis JM.
Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
[Abstract] [Full Text] [Related]
25. HPA axis dysregulation in men with hypersexual disorder.
Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J.
Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
[Abstract] [Full Text] [Related]
26. Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy.
Maes M, Claes M, Schotte C, Delbeke L, Jacquemyn Y, Verkerk R, De Meester I, Scharpé S.
J Psychosom Res; 1992 Feb; 36(2):191-7. PubMed ID: 1560430
[Abstract] [Full Text] [Related]
27. Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
Nelson WH, Orr WW, Stevenson JM, Shane SR.
Arch Gen Psychiatry; 1982 Sep; 39(9):1033-6. PubMed ID: 7115012
[Abstract] [Full Text] [Related]
28. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
Zis AP, Haskett RF, Albala AA, Carroll BJ, Lohr NE.
Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
[Abstract] [Full Text] [Related]
29. Nonsuppression of cortisol in depression and immune function.
Syvälahti E, Eskola J, Ruuskanen O, Laine T.
Prog Neuropsychopharmacol Biol Psychiatry; 1985 Apr; 9(4):413-22. PubMed ID: 4070644
[Abstract] [Full Text] [Related]
30. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
Jakovljević M, Mück-Seler D, Pivac N, Crncević Z.
Neuropsychobiology; 1998 Apr; 37(3):142-5. PubMed ID: 9597670
[Abstract] [Full Text] [Related]
31. Plasma postdexamethasone cortisol levels in schizoaffective disorder.
Meador-Woodruff JH, Greden JF, Grunhaus L, Haskett RF.
Psychiatry Res; 1988 Oct; 26(1):35-42. PubMed ID: 3237905
[Abstract] [Full Text] [Related]
32. What does the dexamethasone suppression test identify?
Krishnan KR, France RD, Pelton S, McCann UD, Manepalli AN, Davidson JR.
Biol Psychiatry; 1985 Sep; 20(9):957-64. PubMed ID: 4027315
[Abstract] [Full Text] [Related]
33. Memory disturbances and dexamethasone suppression test in major depression.
Wauthy J, Ansseau M, von Frenckell R, Mormont C, Legros JJ.
Biol Psychiatry; 1991 Oct 01; 30(7):736-8. PubMed ID: 1958771
[No Abstract] [Full Text] [Related]
34. The dexamethasone suppression and metyrapone tests in depression.
Morphy MA, Fava GA, Perini GI, Molnar G, Zielezny M, Lisansky J.
Psychiatry Res; 1985 Jun 01; 15(2):153-8. PubMed ID: 3862146
[Abstract] [Full Text] [Related]
35. Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers.
Vogel SWN, Bijlenga D, Verduijn J, Bron TI, Beekman ATF, Kooij JJS, Penninx BWJH.
Psychoneuroendocrinology; 2017 May 01; 79():31-39. PubMed ID: 28249186
[Abstract] [Full Text] [Related]
36. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
Tajima-Pozo K, Montes-Montero A, Güemes I, González-Vives S, Díaz-Marsá M, Carrasco JL.
Endocrinol Nutr; 2013 May 01; 60(7):396-403. PubMed ID: 23623464
[Abstract] [Full Text] [Related]
37. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
Meador-Woodruff JH, Haskett RF, Grunhaus L, Akil H, Watson SJ, Greden JF.
Biol Psychiatry; 1987 Sep 01; 22(9):1137-50. PubMed ID: 2958096
[Abstract] [Full Text] [Related]
38. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus.
Cameron OG, Kronfol Z, Greden JF, Carroll BJ.
Arch Gen Psychiatry; 1984 Nov 01; 41(11):1090-5. PubMed ID: 6497572
[Abstract] [Full Text] [Related]
39. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
O'Brien JT, Ames D, Schweitzer I, Colman P, Desmond P, Tress B.
Br J Psychiatry; 1996 Jun 01; 168(6):679-87. PubMed ID: 8773809
[Abstract] [Full Text] [Related]
40. The hypothalamic-pituitary-adrenal system in panic disorder.
Goldstein S, Halbreich U, Asnis G, Endicott J, Alvir J.
Am J Psychiatry; 1987 Oct 01; 144(10):1320-3. PubMed ID: 3661766
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
